Literature DB >> 22512901

Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.

Antonio Nunes1, Khuloud T Al-Jamal, Kostas Kostarelos.   

Abstract

Treatment and diagnosis of neurodegenerative diseases and other CNS disorders are nowadays considered some of the most challenging tasks in modern medicine. The development of effective strategies for the prevention, diagnosis and treatment of CNS pathologies require better understanding of neurological disorders that is still lacking. The use of nanomaterials is thought to contribute to our further understanding of the CNS and the development of novel therapeutic and diagnostic modalities for neurological interventions. Even though the application of nanoparticles in neuroscience is still embryonic, this article attempts to illustrate the use of different types of nanomaterials and the way in which they have been used in various CNS applications in an attempt to limit or reverse neuropathological processes.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512901     DOI: 10.1016/j.jconrel.2012.03.026

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  11 in total

1.  Toxicity of polymeric nanoparticles in vivo and in vitro.

Authors:  Nadine Voigt; Petra Henrich-Noack; Sarah Kockentiedt; Werner Hintz; Jürgen Tomas; Bernhard A Sabel
Journal:  J Nanopart Res       Date:  2014-05-06       Impact factor: 2.253

Review 2.  Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.

Authors:  Anna Lisa Palange; Roberto Palomba; Ilaria F Rizzuti; Miguel Ferreira; Paolo Decuzzi
Journal:  Mol Ther       Date:  2017-03-22       Impact factor: 11.454

3.  Impact of gold nanoparticles on brain of mice infected with Schistosoma mansoni.

Authors:  Mohamed A Dkhil; Amira A Bauomy; Marwa S M Diab; Rizwan Wahab; Denis Delic; Saleh Al-Quraishy
Journal:  Parasitol Res       Date:  2015-07-01       Impact factor: 2.289

Review 4.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

Review 5.  Dendrimer advances for the central nervous system delivery of therapeutics.

Authors:  Leyuan Xu; Hao Zhang; Yue Wu
Journal:  ACS Chem Neurosci       Date:  2013-12-05       Impact factor: 4.418

Review 6.  Nanomedicine in cerebral palsy.

Authors:  Bindu Balakrishnan; Elizabeth Nance; Michael V Johnston; Rangaramanujam Kannan; Sujatha Kannan
Journal:  Int J Nanomedicine       Date:  2013-11-01

7.  Effect of Intra CA1 and Intraperitoneal Administration of Opioid Receptor Modulating Agents on The Anxiolytic Properties of Nano and Conventional ZnO in Male Rats.

Authors:  Mozhgan Torabi; Mahnaz Kesmati; Hooman Eshagh Harooni; Hosein Najafzadeh Varzi
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

8.  Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.

Authors:  Ajay Vikram Singh; Manish Khare; W N Gade; Paolo Zamboni
Journal:  Autoimmune Dis       Date:  2012-12-30

9.  From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Authors:  Claire Géral; Angelina Angelova; Sylviane Lesieur
Journal:  Pharmaceutics       Date:  2013-02-08       Impact factor: 6.321

Review 10.  Emerging insights into barriers to effective brain tumor therapeutics.

Authors:  Graeme F Woodworth; Gavin P Dunn; Elizabeth A Nance; Justin Hanes; Henry Brem
Journal:  Front Oncol       Date:  2014-07-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.